J&J Drug Receives FDA Approval for Preventing and Treating Plague

by Kathy Jones on  April 30, 2012 at 8:19 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has given its approval for Johnson & Johnson' levofloxacin drug for preventing and treating plague.

The FDA said that the drug has been approved for reducing the risk of plague after a person has been exposed to bacterium Yersinia pestis.
 J&J Drug Receives FDA Approval for Preventing and Treating Plague
J&J Drug Receives FDA Approval for Preventing and Treating Plague

The drug, to be sold under the brand name Levaquin, was developed by Johnson & Johnson after the company was approached by the US government following fears that Yersinia pestis could be used as a biological weapon by terrorists.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Bioterrorism Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive